The authors focused on the setting of an oligorecurrent hormone-sensitive PCa, showing that [68Ga]Ga-PSMA-11 PET/CT guided MDT with stereotactic radiotherapy related to an advantage in terms of ADT-free survival compared to [18F]F-Fluorocholine PET/CT. This evidence concerns the gene FOLH1 and posterior cortical atrophy.